Inventor · disambiguated record
Vladimir Hanes
Also filed as: HANES VLADIMIR
3 granted patents·9 pending applications·5 citations·filing 2007–2020
63Inventor score
Files withSPROUT PHARMACEUTICALS INC5HANES VLADIMIR3BAYER SCHERING PHARMA OY1BOEHRINGER INGELHEIM INT1SCHAFER MATTHIAS1
Top patents by PatentIndex Score
12 records- 0183US9949969B2Treatment of vasomotor symptomsSPROUT PHARMACEUTICALS INC·Filed 2017·Granted Apr 24, 2018·3 cites·18 claims
- 0275US10166230B2Treatment of vasomotor symptomsSPROUT PHARMACEUTICALS INC·Filed 2014·Granted Jan 1, 2019·2 cites·17 claims
- 0369US2011136825A1Treatment of Vasomotor SymptomsBOEHRINGER INGELHEIM INT·Filed 2008·Application pending·0 cites
- 0461US2020253962A1Treatment of vasomotor symptomsSPROUT PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0561US2014005203A1Treatment of Vasomotor SymptomsSPROUT PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 0660US10596170B2Treatment of vasomotor symptomsSPROUT PHARMACEUTICALS INC·Filed 2018·Granted Mar 24, 2020·0 cites·18 claims
- 0750US2009142313A1Vaginal delivery systemBAYER SCHERING PHARMA OY·Filed 2008·Application pending·0 cites
- 0848US2010285097A1Vaginal delivery systemTALLING CHRISTINE·Filed 2008·Application pending·0 cites
- 0948US2008021003A1Extended step-down estrogen regimenHANES VLADIMIR·Filed 2007·Application pending·0 cites
- 1048US2007275941A1Salt sensitivity and prevention of hypertension with drospirenoneHANES VLADIMIR·Filed 2007·Application pending·0 cites
- 1146US2010021529A1Step-down estrogen regimen for women receiving estrogen therapySCHAFER MATTHIAS·Filed 2007·Application pending·0 cites
- 1241US2009023693A1New drospirenone/17beta-estradiol regimen, pharmaceutical combination product and kit for performing this regimenHANES VLADIMIR·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vladimir Hanes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →